Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
GlaxoSmithKline is recalling specific lots of Nicorette lozenges because they failed quality specifications, including being overly thick, soft, and sub or superpotent.
Ohm Laboratories is recalling 29,790 blister packs of Loratadine and Pseudoephedrine Sulfate Extended Release Tablets due to unacceptable blister defects.
GlaxoSmithKline is recalling Nicorette and store-brand nicotine lozenges because they failed quality specifications, including being overly thick, soft, and sub or superpotent.
GlaxoSmithKline is recalling Nicorette and store-brand nicotine lozenges because they failed specifications for thickness, softness, and potency.
Upsher Smith Laboratories is recalling 36 bottles of Oxandrolone Tablets, USP, 10 mg, because they were packaged without primary labels.
GlaxoSmithKline is recalling specific lots of Nicorette Lozenges Mini because they failed quality specifications, including being overly thick, soft, and sub or superpotent.
GlaxoSmithKline is recalling a specific lot of Nicorette Lozenge and NicoDerm CQ combination packs because the lozenges failed quality specifications.
GlaxoSmithKline is recalling specific lots of Nicorette and Nicoderm CQ products because the lozenges failed quality specifications, including being overly thick, soft, and having incorrect potency.
Haute Health is recalling Virilis Pro dietary supplements because they may contain unapproved active ingredients found in FDA-approved erectile dysfunction drugs.
Haute Health, LLC is recalling PHUK Sexual Enhancement Ultimate Pleasure because it may contain unapproved active ingredients found in FDA-approved erectile dysfunction drugs.
B @ B Trade Inc. is recalling Slim Fortune capsules because they contain undeclared sibutramine and were marketed without FDA approval.
B @ B Trade Inc. is recalling Lidiy capsules because the dietary supplement was marketed without FDA approval and contains undeclared sibutramine.
Hospira, Inc. is recalling 1% Lidocaine Hydrochloride Injection vials because oxidized stainless steel was found in the product.
B @ B Trade Inc. is recalling Slim Expert softgels because they contain undeclared sibutramine and were marketed without FDA approval.
Haute Health, LLC is recalling Prolifta dietary supplements because they may contain unapproved active ingredients used in erectile dysfunction drugs.
Zions RX Formulations is recalling 450 vials of Calcium Gluconate 10% for Injection due to a report of microbial contamination.
The FDA is recalling Vicerex male sexual enhancer capsules because laboratory analysis found undeclared tadalafil, an unapproved drug ingredient.
Slim Beauty USA is recalling Dream Body Slimming Capsules because they contain undeclared sibutramine, an unapproved new drug not currently marketed in the United States.
Slim Beauty USA is recalling Dr. Ming's Chinese Capsule because it contains undeclared sibutramine and phenolphthalein, making it an unapproved new drug.
Slim Beauty USA is recalling Magic Slim capsules nationwide because they contain undeclared sibutramine and phenolphthalein, making them unapproved new drugs.
Terra-Medica Inc. is recalling Pleo Not Suppositories 3X due to penicillin cross-contamination. The affected homeopathic medicine was distributed in the US, Canada, and the Philippines.
Terra-Medica Inc. is recalling Pleo-Fort DROPS 5X homeopathic medicine due to penicillin cross-contamination. The product was distributed in the US, Canada, and the Philippines.
Terra-Medica Inc. is recalling Pleo Not Tablets 5X because of penicillin cross contamination. The affected homeopathic medicine was distributed in the US, Canada, and the Philippines.
Terra-Medica Inc. is recalling Pleo Quent homeopathic medicine because of penicillin cross-contamination. The product was distributed in the US, Canada, and the Philippines.
Terra-Medica Inc. is recalling specific batches of Pleo Not Ointment because of penicillin cross contamination. The product was distributed in the US, Canada, and the Philippines.